loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

List of Certificates of Suitability (CEPs) for cep_2022_237___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Filters Filter
Cross PopUp
FILTER :

filter

01 ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN (1)

filter

01 Lisinopril dihydrate, Anhydride Process (1)

filter

01 China (1)

filter

01 Valid (1)

URL Supplier Web Content
CEP 2022-237 - Rev 01
Valid
Chemical
2024-01-24
1120
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for CEP 2022-237 - Rev 01 of Zhejiang Huahai Pharmaceutical Co., Ltd. Linhai Cn

Looking for Certificates of Suitability (CEPs) for CEP 2022-237 - Rev 01 of Zhejiang Huahai Pharmaceutical Co., Ltd. Linhai Cn 1

20

Zhejiang Huahai Pharmaceutical Co., Ltd. Linhai Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Lisinopril dihydrate, Anhydride Process, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-237 - Rev 01

This Chemical Type CEP, issued on January 24, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1120 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY